Purchases and Sales Made in Q4 2024 in Vertex Pharmaceuticals Inc (VRTX)
This table provides information about the institutional ownership of Vertex Pharmaceuticals Inc (VRTX) during Q4 2024. The information is specifically focused on institutions that hold shares of VERTEX PHARMACEUTICALS INC .
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 06, 2025
Q4 2024
|
Proficio Capital Partners LLC
Newton, MA |
SELL
|
- |
-393K- 99.75% |
$156M - $203M
|
978
$470K
|
|
|
Feb 13, 2025
Q4 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-420K- 18.22% |
$166M - $217M
|
1.88M
$905M
|
|
|
Feb 07, 2025
Q4 2024
|
Amundi
Paris, I0 |
SELL
|
- |
-478K- 12.72% |
$190M - $247M
|
3.28M
$1.58B
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-615K- 8.88% |
$244M - $318M
|
6.31M
$3.03B
|
|
|
Feb 12, 2025
Q4 2024
|
Massachusetts Financial Services CO
Boston, MA |
SELL
|
- |
-617K- 21.24% |
$245M - $319M
|
2.29M
$1.1B
|
|
|
Jan 24, 2025
Q4 2024
|
Jennison Associates LLC
|
SELL
|
- |
-1.23M- 22.21% |
$489M - $637M
|
4.32M
$2.07B
|
|
|
Feb 12, 2025
Q4 2024
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-3.45M- 46.83% |
$1.37B - $1.78B
|
3.92M
$1.88B
|